191 related articles for article (PubMed ID: 34985387)
21. lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis.
Li X; Mo J; Li J; Chen Y
Mol Med Rep; 2020 Dec; 22(6):5181-5190. PubMed ID: 33174006
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of lncRNA CASC2 promotes the postoperative local recurrence of early oral squamous cell carcinoma.
Dong Y; Wu W
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):605-610. PubMed ID: 30467776
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
24. CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.
Yu X; Zheng H; Tse G; Zhang L; Wu WKK
Cell Prolif; 2018 Dec; 51(6):e12506. PubMed ID: 30094876
[TBL] [Abstract][Full Text] [Related]
25. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA CASC2 inhibits tumorigenesis via the miR-181a/PLXNC1 axis in melanoma.
Wang Z; Wang X; Zhou H; Dan X; Jiang L; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Mar; 50(3):263-272. PubMed ID: 29514220
[TBL] [Abstract][Full Text] [Related]
27. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
28. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
29. Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1.
Zhang Y; Qian W; Feng F; Cao Q; Li Y; Hou Y; Zhang L; Fan J
Oncol Res; 2019 Feb; 27(3):371-377. PubMed ID: 29422114
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.
Wang D; Gao ZM; Han LG; Xu F; Liu K; Shen Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4584-4590. PubMed ID: 29131257
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1.
Xing HB; Qiu HM; Li Y; Dong PF; Zhu XM
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4777-4783. PubMed ID: 31210307
[TBL] [Abstract][Full Text] [Related]
32. RNPC1 inhibits non-small cell lung cancer progression via regulating miR-181a/CASC2 axis.
Yang L; Zhang Y; Ling C; Heng W
Biotechnol Lett; 2018 Mar; 40(3):543-550. PubMed ID: 29288351
[TBL] [Abstract][Full Text] [Related]
33. CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.
Liu QY; Gao LY; Xu L; Zhang XL; Zhang LJ; Gong XL; Luo SB; Zhao R; Cheng RC
Kaohsiung J Med Sci; 2021 Apr; 37(4):268-275. PubMed ID: 33336500
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells.
Cao Y; Xu R; Xu X; Zhou Y; Cui L; He X
Mol Med Rep; 2016 Jul; 14(1):1019-25. PubMed ID: 27222255
[TBL] [Abstract][Full Text] [Related]
35. LncRNA PITPNA-AS1 boosts the proliferation and migration of lung squamous cell carcinoma cells by recruiting TAF15 to stabilize HMGB3 mRNA.
Ren P; Xing L; Hong X; Chang L; Zhang H
Cancer Med; 2020 Oct; 9(20):7706-7716. PubMed ID: 32871048
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway.
Zhu H; Liu Q; Yang X; Ding C; Wang Q; Xiong Y
Cancer Gene Ther; 2022 Aug; 29(8-9):1285-1295. PubMed ID: 35228660
[TBL] [Abstract][Full Text] [Related]
37. PLAU, transcriptionally negatively regulated by GATA6, promotes lung squamous carcinoma cell proliferation and migration.
Guo J; Wang H; Huang C; Lai C; Shang W; Luo S; Chen L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119744. PubMed ID: 38702016
[TBL] [Abstract][Full Text] [Related]
38. NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC.
Zhou X; Bao W; Zhang D; Yang Y; Du X; Qiu G
Cancer Biol Ther; 2021 Mar; 22(3):196-203. PubMed ID: 33629937
[TBL] [Abstract][Full Text] [Related]
39. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
40. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
Lu L; Dai Z; Luo Q; Lv G
Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
